Optimizing IVF outcomes for women with diminished oocyte reserve

References

• Steptoe P, Edwards R. Birth after the reimplantation of a human embryo. Lancet 12, 366 (1978).
   Google Scholar
• Laufer N, DeCherney AH, Haseline FP et al. The use of high-dose human menopausal gonadotropin in an in vitro fertilization program. Fertil. Steril. 40, 734–741 (1983).
   PubMed Web of Science ®Google Scholar
• Fleming R, Adam AH, Barlow DH, Black WP, MacNaughton MC, Coutts JR. A new systematic treatment for infertile women with abnormal hormone profiles. Br. J. Obstet. Gynaecol. 89, 80–83 (1982).
   PubMedGoogle Scholar
• Bancsi LF, Broekmans FJ, Mol BW, Habbema JD, te Velde ER. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil. Steril. 79, 1091–1100 (2003).
   PubMed Web of Science ®Google Scholar
• Akande VA, Fleming CF, Hunt LP, Keay SD, Jenkins JM. Biological versus chronological ageing of oocytes distinguishable by raised FSH levels in relation to the success of IVF treatment. Hum. Reprod. 17, 2003–2008 (2002).
   PubMed Web of Science ®Google Scholar
• Muasher SJ, Oehninger S, Simonetti S et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil. Steril. 50, 298–307 (1988).
   PubMed Web of Science ®Google Scholar
• Fenichel P, Grimaldi M, Olivero J-F, Donzeau M, Gillet J-Y, Harter M. Predictive value of hormonal profiles before stimulation for in vitro fertilization. Fertil. Steril. 51, 845–849 (1989).
   PubMed Web of Science ®Google Scholar
• Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil. Steril. 51, 651–654 (1989).
   PubMed Web of Science ®Google Scholar
• Chang MY, Chiang CH, Hsieh TT, Soong YK, Hsu KH. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil. Steril. 69, 505–510 (1998).
   PubMed Web of Science ®Google Scholar
• Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil. Steril. 64, 991–994 (1995).
   PubMed Web of Science ®Google Scholar
• Roberts JE, Spandorfer S, Fasouliotis SJ, Kashyap S, Rosenwaks Z. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization. Fertil. Steril. 83, 37–41 (2005).
   Google Scholar
• Creus M, Penarrubia J, Fabregues F et al. Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum. Reprod. 15, 2341–2346 (2000).
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. Anti-Müllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil. Steril. 94, 2824–2827 (2010).
   PubMed Web of Science ®Google Scholar
• Yanushpolsky E, Hurwitz S, Tikh E, Racowsky C. Predictive usefulness of cycle day 10 follicle stimulating hormone level in a clomiphene challenge test for in vitro fertilization outcome in women younger than 40 years of age. Fertil. Steril. 80, 111–115 (2003).
   Google Scholar
• Csemiczky G, Harlin J, Fried G. Predictive power of clomiphene citrate challenge test for failure of in vitro fertilization treatment. Acta. Obstet. Gynecol. Scand. 81, 954–961 (2002).
   Google Scholar
• Scott RT Jr, Illions EH, Kost ER, Dellinger C, Hoffmann GE, Navot D. Evaluation of the significance of the estradiol response during the clomiphene challenge test. Fertil. Steril. 60, 242–246 (1993).
   Google Scholar
• Baart EB, Martini E, Eijkemans MJ et al. Milder ovarian stimulation for in vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum. Reprod. 22, 980–988 (2007).
   PubMed Web of Science ®Google Scholar
• Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott RT Jr. Live birth outcome with trophectoderm biopsy, blastocyst vitrification and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients. Fertil. Steril. 96, 638–640 (2011).
   PubMed Web of Science ®Google Scholar
• Nasseri A, Mukherjee T, Grifo JA, Noyes N, Krey L, Copperman AB. Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy. Fertil. Steril. 71, 715–718 (1999).
   PubMed Web of Science ®Google Scholar
• Kolibianakis E, Zikopoulos K, Camus M, Tounaye H, Van Steirteghem A, Devroey P. Modified natural cycles for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels as a last resort prior to oocyte donation. Hum. Reprod. 19, 2545–2549 (2004).
   PubMedGoogle Scholar
• Check JH, Nazari P, Check ML, Choe JK, Liss JR. Prognosis following in vitro fertilization-embryo transfer (IVF-ET) in patients with elevated day 2 or 3 serum follicle stimulating hormone (FSH) is better in younger vs older patients. Clin. Exp. Obst. Gyn. 29, 42–44 (2002).
   Google Scholar
• Katt JA, Duncan JA, Herbon L, Barkan A, Marshall JC. The frequency of gonadotropin releasing hormone stimulation determines the number of pituitary gonadotropin-releasing hormone receptors. Endocrinology 116, 2113–2115 (1985).
   Google Scholar
• Check JH, Summers-Chase D, Yuan W, Horwath D, Wilson C. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil. Steril. 87, 749–756 (2007).
   PubMed Web of Science ®Google Scholar
• Check JH, Liss J. The effect of diminished oocyte reserve in younger women (age <37) on pregnancy rates in natural cycles. 67th Annual Meeting of the American Society for Reproductive Medicine, Orlando, FL, USA, 15–19 October 2011. Fertil. Steril. 96(3 Suppl.), S197, poster # P-305 (2011).
   Google Scholar
• Check JH, Adelson H, Lurie D, Jamison T. The effect of the short follicular phase on subsequent conception. Gynecol. Obstet. Invest. 34, 180–183 (1992).
   PubMed Web of Science ®Google Scholar
• Check JH, Liss JR, Shucoski K, Check ML. Effect of short follicular phase with follicular maturity on conception outcome. Clin. Exp. Obst. Gyn. 30, 195–196 (2003).
   Google Scholar
• Katsoff B, Check MD. Successful pregnancy in a 45-year-old woman with elevated day 3 serum follicle stimulating hormone and a short follicular phase. Clin. Exp. Obstet. Gynecol. 32, 97–98 (2005).
   Google Scholar
• Check JH, Chase JS, Nowroozi K, Dietterich CJ. Premature luteinization Treatment and incidence in natural cycles. Hum. Reprod. 6, 190–193 (1991).
   PubMed Web of Science ®Google Scholar
• Check JH, Nowroozi K, Wu CH, Adelson HG, Lauer C. Ovulation inducing drugs versus progesterone therapy for infertility in patients with luteal phase defects. Int. J. Fertil. 33, 252–256 (1988).
   PubMedGoogle Scholar
• Check JH. Progesterone therapy versus follicle maturing drugs - possible opposite effects on embryo implantation. Clin. Exp. Obst. Gyn. 29, 5–10 (2002).
   PubMedGoogle Scholar
• Check JH. Ovulation defects despite regular menses: Part III. Clin. Exp. Obstet. Gyncol. 34, 133–136 (2007).
   Google Scholar
• Menken J, Trussell J, Larsen U. Age and infertility. Science 233, 1389–1394 (1986).
   PubMed Web of Science ®Google Scholar
• Laufer N, Simon A, Samueloff A, Yaffe H, Milwidsky A, Gielchinsky Y. Successful spontaneous pregnancies in women older than 45 years. Fertil. Steril. 81, 1328–1332 (2004).
   PubMed Web of Science ®Google Scholar
• Check JH, Chase JS, Wu CH, Adelson HG. Case Report: Ovulation induction and pregnancy using an estrogen gonadotropin stimulation technique in a menopausal woman with marked hypoplastic ovaries. Am. J. Obstet. Gynecol. 160, 405–406 (1989).
   Google Scholar
• Shanis BS, Check JH. Spontaneous ovulation and successful pregnancy despite bilateral streaked ovaries. Infertility 15, 70–77 (1992).
   Google Scholar
• Check JH. The concept and treatment methodology for inducing ovulation in women in apparent premature menopause. Clin. Exp. Obst. Gyn. 36, 70–73 (2009).
   Google Scholar
• Check JH, Nowroozi K, Chase JS, Nazari A, Shapse D, Vaze M. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil. Steril. 53(5), 811–816 (1990).
   Google Scholar
• Check JH. A practical approach to the prevention of miscarriage: Part 1 – progesterone therapy. Clin. Exp. Obst. Gyn. 36, 203–208 (2009).
   Google Scholar
• Check JH, Chase J. Ovulation induction in hypergonadotropic amenorrhea with estrogen and human menopausal gonadotropin therapy. Fertil. Steril. 42, 919–922 (1984).
   Google Scholar
• Check JH. The multiple uses of ethinyl estradiol for treating infertility. Clin. Exp. Obst. Gyn. 37, 249–251 (2010).
   Google Scholar
• Check JH, Chase JS, Spence M. Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy. Am. J. Obstet. Gynecol. 160, 114–115 (1989).
   PubMed Web of Science ®Google Scholar
• Check JH, Wu CH, Check M. The effect of leuprolide acetate in aiding induction of ovulation in hypergonadotropic hypogonadism: A case report. Fertil. Steril. 49(3), 542–543 (1988).
   Google Scholar
• Check JH, Katsoff B. Ovulation induction and pregnancy in a woman with premature menopause following gonadotropin suppression with the gonadotropin releasing hormone antagonist, cetrorelix – a case report. Clin. Exp. Obstet. Gynecol. 35, 10–12 (2008).
   PubMed Web of Science ®Google Scholar
• Check ML, Check JH, Kaplan H. Pregnancy despite imminent ovarian failure and extremely high endogenous gonadotropins and therapeutic strategies: Case report and review. Clin. Exp. Obst. Gyn. 31, 299–301 (2004).
   Google Scholar
• Check JH, Katsoff B. Successful pregnancy with spontaneous ovulation in a woman with apparent premature ovarian failure who failed to conceive despite four transfers of embryos derived from donated oocytes. Clin. Exp. Obst. Gyn. 33, 13–15 (2006).
   Google Scholar
• Check JH. Multiple follicles in an unstimulated cycle despite elevated gonadotropins in a perimenopausal female. Gynecol. Obstet. Invest. 33, 190–192 (1992).
   Google Scholar
• Check JH. Ovulation and successful pregnancy in a woman with ovarian failure after hypophysectomy and gonadotropin therapy. Am. J. Obstet. Gynecol. 162, 775–776 (1990).
   Google Scholar
• Check JH. Gonadotropinoma presenting as a case of pseudo-ovarian failure changing to macroprolactinoma. Clin. Exp. Obst. Gyn. 40, 295–296 (2013).
   Google Scholar
• Check JH, Adelson HG, Dietterich C, Stern J. Pelvic sonography can predict ovum release in gonadotropin treated patients as determined by pregnancy rate. Hum. Reprod. 5(3), 234–236 (1990).
   Google Scholar
• Check JH, Nazari A, Barnea ER, Weiss W, Vetter BH. The efficacy of short-term gonadotrophin-releasing hormone agonists versus human chorionic gonadotrophin to enable oocyte release in gonadotrophin stimulated cycles. Hum. Reprod. 8, 568–571 (1993).
   PubMed Web of Science ®Google Scholar
• Check JH, Dietterich C, Lurie D. Non-homogeneous hyperechogenic pattern 3 days after embryo transfer is associated with lower pregnancy rates. Hum. Reprod. 15(5), 1069–1074 (2000).
   Google Scholar
• Check JH, Gandica R, Dietterich C, Lurie D. Evaluation of a nonhomogeneous endometrial echo pattern in the midluteal phase as a potential factor associated with unexplained infertility. Fertil. Steril. 79, 590–593 (2003).
   Google Scholar
• Check JH. Minimal and natural stimulations for IVF. In: Advances in Embryo Transfer. ( Chapter 2). Wu B ( Ed.). InTech, Rijekia, Croatia, 21–36 (2012).
   Google Scholar
• Check JH. Pharmacological options in resistant ovary syndrome and premature ovarian failure. Clin. Exp. Obst. Gyn. 33, 71–77 (2006).
   Google Scholar
• Shastri SM, Barbieri E, Kligman I, Schoyer KD, Davis OK, Rosenwaks Z. Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide. Fertil. Steril. 95, 592–595 (2011).
   PubMed Web of Science ®Google Scholar
• Chang EM, Han JE, Won HJ, Kim YS, Yoon TK, Lee WS. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in vitro fertilization. J. Assist. Reprod. Genet. 29, 225–230 (2012).
   PubMed Web of Science ®Google Scholar
• Casson PR, Santoro N, Elkind-Hirsch K et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six month trial. Fertil. Steril. 70, 107–110 (1998).
   PubMed Web of Science ®Google Scholar
• Barad D, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil. Steril. 84, 756 (2005).
   PubMed Web of Science ®Google Scholar
• Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yeilds, embryo grade and cell number in IVF. Hum. Reprod. 21, 2845–2849 (2006).
   PubMed Web of Science ®Google Scholar
• Sonmezer M, Ozmen B, Cil AP et al. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders. Reprod. BioMed. Online 19, 508–513 (2009).
   PubMed Web of Science ®Google Scholar
• Mamas L, Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil. Steril. 91, 644–646 (2009).
   PubMed Web of Science ®Google Scholar
• Mamas L, Mamas E. Dehydroepiandrosterone supplementation in assisted reproduction: rationale and results. Curr. Opin. Obstet. Gynecol. 21, 306–308 (2009).
   PubMed Web of Science ®Google Scholar
• Haning RV Jr, Hackett RJ, Flood CA, Loughlin JS, Zhao QY, Longcope C. Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J. Clin. Endocrinol. Metab.76, 1301–1307 (1993).
   PubMed Web of Science ®Google Scholar
• Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum. Reprod. 15, 2129–2132 (2000).
   PubMed Web of Science ®Google Scholar
• Borman E, Check JH, Mitchell-Williams J, Cohen R. No evidence to support the concept that low serum dehydroepiandrosterone (DHEA) sulfate (s) levels are associated with less ocoyte production or lower pregnancy rates. Clin. Exp. Obst. Gyn. 39, 429–431 (2012).
   Google Scholar
• Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin. Endocrinol. Metab. 15, 213–228 (1986).
   PubMedGoogle Scholar
• Li L, Ferin M, Sauer MV, Lobo RA. Dehydroepiandrosterone in follicular fluid is produced locally, and levels correlate negatively with in vitro fertilization outcomes. Fertil. Steril. 95, 1830–1832 (2011).
   Google Scholar
• Check JH, Summers D, Nazari A, Choe J. Successful pregnancy following in vitro fertilization-embryo transfer despite imminent ovarian failure. Clin. Exp. Obst. Gyn. 27(2), 97–99 (2000).
   Google Scholar
• Check ML, Check JH, Choe JK, Berger GS. Successful pregnancy in a 42-year-old woman with imminent ovarian failure following ovulation induction with ethinyl estradiol without gonadotropins and in vitro fertilization. Clin. Exp. Obst. Gyn. 29, 11–14 (2002).
   Google Scholar
• Check JH, Pinto J, Liss JR, Choe JK. Improved pregnancy outcome for women with decreased ovarian oocyte reserve and advanced reproductive age by performing in vitro fertilization-embryo transfer. Clin. Exp. Obst. Gyn. 35, 167–169 (2008).
   Google Scholar
• Check JH, Giangreco J. Three successful pregnancies following natural conception over an 8 year time span despite serum follicle stimulating hormone level greater than 15 mIU/mL – case report. Clin. Exp. Obst. Gyn. 36, 12–14 (2009).
   Google Scholar
• Check JH, Katsoff B. Three successful pregnancies with in vitro fertilization embryo transfer over an eight year time span despite elevated basal serum follicle stimulating hormone levels – Case report. Clin. Exp. Obst. Gyn. 32, 217–221 (2005).
   Google Scholar
• Check JH, Cohen R. Live fetus following embryo transfer in a woman with diminished egg reserve whose maximal endometrial thickness was less than 4 mm. Clin. Exp. Obst. Gyn. 38, 330–332 (2011).
   PubMed Web of Science ®Google Scholar
• Check JH, Check ML, Katsoff D. Three pregnancies despite elevated serum FSH and advanced age: Case report. Hum. Reprod. 15(8), 1709–1712 (2000).
   Google Scholar
• Check JH. Successful pregnancy despite advanced age and elevated serum follicle stimulating hormone levels - A case report. Clin. Exp. Obst. Gyn. 27, 171–172 (2000).
   Google Scholar
• Check JH, Chern R, Amui J. Successful pregnancy following in vitro fertilization embryo transfer in a 46-year-old woman with diminished oocyte reserve as evidenced by a high day 3 serum estradiol. Clin. Exp. Obst. Gyn. 38, 209–210 (2011).
   Google Scholar
• Check JH, Choe JK, Cohen R. Successful pregnancy following a single fresh embryo transfer in a 45-year-old woman whose early follicular phase serum follicle stimulating hormone was 29 mIU/mL. Clin. Exp. Obst. Gyn. 38, 335–337 (2011).
   Google Scholar
• Labarta E, Bosch E, Alama P, Rubio C, Rodrigo L, Pellicer A. Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles. J. Clin. Endocrinol. Metab. 97, E1987–E1994 (2012).
   Google Scholar
• Heijnen EME, Eijkemans MJC, De Klerk C et al. A mild treatment strategy for in vitro fertilization: a randomized non-inferiority trial. Lancet 369, 743–749 (2007).
   PubMed Web of Science ®Google Scholar
• Eijkemans MJC, Heijnen EMEW, de Klerk C, Habbema JDF, Fauser BCJM. Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial. Hum. Reprod. 21, 344–351 (2006).
   PubMed Web of Science ®Google Scholar
• Polinder S, Heijnen EMEW, Macklon NS, Habbema JDF, Fauser BJCM, Eijkemans MJC. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Hum. Reprod. 23, 316–323 (2008).
   PubMed Web of Science ®Google Scholar
• Weigert M, Krischker U, Pohl M, Poschalko G, Kindermann C, Feichtinger W. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Fertil. Steril. 78, 34–39 (2002).
   PubMed Web of Science ®Google Scholar
• Check JH: Mild ovarian stimulation. J. Assist. Reprod. Genet. 24, 621–627 (2007).
   Google Scholar
• Check JH, Choe JK, Nazari A, Fox F, Swenson K. Fresh embryo transfer is more effective than frozen ET for donor oocyte recipients but not for donors. Hum. Reprod. 16, 1403–1408 (2001).
   Google Scholar
• Cobo A. Oocyte vitrification: a watershed in ART. Fertil. Steril. 98, 600–601 (2012).
   Google Scholar
• Dierich A, Sairam MR, Monaco L et al. Impairing follicle stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Natl Acad. Sci. USA 95, 13612–13617 (1998).
   PubMed Web of Science ®Google Scholar
• Aittomaki K, Diguez Lucena J, Pakarinen P et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82, 959–968 (1995).
   PubMed Web of Science ®Google Scholar
• Touraine P, Beau I, Gougeon A et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol. Endocrinol. 13, 1844–1854 (1999).
   PubMedGoogle Scholar
• Themmen APN, Huhtaniemi I. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocrine. Rev. 21, 551–583 (2000).
   PubMed Web of Science ®Google Scholar
• Doherty E, Pakarinen P, Tiitinen A et al. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J. Clin. Endocrinol. Metab. 87, 1151–1155 (2000).
   Google Scholar
• Meduri G, Touraine P, Beau I et al. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J. Clin. Endocrinol. Metab. 88, 3491–3498 (2003).
   PubMed Web of Science ®Google Scholar
• Conway G, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle-stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin. Endocrinol. 51, 97–99 (1999).
   PubMed Web of Science ®Google Scholar
• Arnhold IJ, Latronico AC, Batista MC, Carvalho FM, Chrousos GP, Mendonca BB. Ovarian resistance to luteinizing hormone: a novel cause of amenorrhea and infertility. Fertil. Steril. 67, 394–397 (1997).
   PubMedGoogle Scholar
• Takashashi K, Karino K, Kanasaki H et al. Influence of missense mutation and silent mutation of LH beta-subunit gene in Japanese patients with ovulatory disorders. Eur. J. Hum. Genet. 11, 402–408 (2003).
   Google Scholar
• Takahashi K, Ozaki T, Kanasaki H, Miyazaki K. Successful pregnancy in a woman with ovarian failure associated with mutation in the β-subunit of luteinizing hormone. Horm. Res. 55, 258–263 (2001).
   PubMedGoogle Scholar
• Takahashi K, Kurioka H, Kanasaki H, Okada M, Ozaki T, Miyazaki K. A case of a pregnant woman with luteal insufficiency and a mutation in the beta-subunit of luteinizing hormone. Int. J. Fertil. Womens Med. 45, 327–334 (2000).
   PubMedGoogle Scholar
• Artini PG, Ruggiero M, Papini F et al. Chromosomal abnormalities in women with premature ovarian failure. Gynecol. Endoc. 26, 717–724 (2010).
   PubMed Web of Science ®Google Scholar